The Kids Vaccine Initiative for Strep A (VISTA)

VISTA aims to reduce the serious health inequities caused by Group A Streptococcus (Strep A) by accelerating the development of a world-first vaccine.

A safe and effective vaccine offers a practical and impactful way to reduce this impact, lessen the need for antibiotics and improve long-term health outcomes.

VISTA focuses on three key objectives

1. Demonstrating vaccine safety and effectiveness: evaluating Strep A vaccine candidates for the prevention of Strep A pharyngitis in school-aged children.
2. Forging global partnerships: supporting the clinical development, regulatory approval and licensure of successful vaccine candidates.
3. Ensuring equitable access: making sure the populations at highest risk globally, including First Nations Australians and communities in low- and middle-income countries, are among the first to benefit from a proven safe and effective vaccine.